MedTrace Logo

Feasibility and Reliability of Multimodal Evoked Potentials in an International Multicenter Setting

NCT03047460 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2019-03-06

No results posted yet for this study

Summary

Study Objectives and Endpoints:

Objective:

The primary objective of the study is to evaluate the feasibility and test-retest reliability of MEP's and (SSEP's) in a multicenter clinical trial in healthy subjects and subjects with MS.

Endpoints:

The primary reliability endpoint will be the intraclass correlation coefficient (ICC) of the following evoked potential parameters

Conditions

Interventions

OTHER

multimodal evoked potentials

Sponsors & Collaborators

  • Clinique Neuro-Outaouais

    lead OTHER

Principal Investigators

  • François Jacques, MD · Clinique Neuro-Outaouais

Eligibility

Min Age
18 Years
Max Age
58 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03047460 on ClinicalTrials.gov